Treace Medical Concepts, Inc.
TMCI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $462 | $776 | $1,271 | $1,010 |
| - Cash | $11 | $13 | $19 | $106 |
| + Debt | $70 | $70 | $69 | $29 |
| Enterprise Value | $520 | $833 | $1,320 | $933 |
| Revenue | $209 | $187 | $142 | $94 |
| % Growth | 11.9% | 31.9% | 50.2% | – |
| Gross Profit | $168 | $152 | $114 | $78 |
| % Margin | 80.4% | 81.2% | 80.6% | 82.1% |
| EBITDA | -$42 | -$39 | -$36 | -$16 |
| % Margin | -20.1% | -20.8% | -25.6% | -16.7% |
| Net Income | -$56 | -$50 | -$43 | -$21 |
| % Margin | -26.6% | -26.5% | -30.2% | -21.8% |
| EPS Diluted | -0.9 | -0.81 | -0.77 | -0.38 |
| % Growth | -11.1% | -5.2% | -102.6% | – |
| Operating Cash Flow | -$37 | -$35 | -$31 | -$17 |
| Capital Expenditures | -$12 | -$11 | -$15 | -$3 |
| Free Cash Flow | -$49 | -$46 | -$45 | -$20 |